<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang J</submitter><funding>Swiss National Science Foundation</funding><funding>PSI - Paul Scherrer Institute</funding><pagination>9-21</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11599313</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>52(1)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>The angiotensin converting enzyme 2 (ACE2) plays a regulatory role in the cardiovascular system and serves SARS-CoV-2 as an entry receptor. The aim of this study was to synthesize and evaluate radiofluorinated derivatives of the ACE2 inhibitor MLN-4760. [&lt;sup>18&lt;/sup>F]F-MLN-4760 and [&lt;sup>18&lt;/sup>F]F-Aza-MLN-4760 were demonstrated to be suitable for non-invasive imaging of ACE2, potentially enabling a better understanding of its expression dynamics.&lt;h4>Methods&lt;/h4>Computational molecular modeling, based on the structures of human ACE2 (hACE2) and mouse ACE2 (mACE2), revealed that the ACE2-binding modes of F-MLN-4760 and F-Aza-MLN-4760 were similar to that of MLN-4760. Co-crystallization of the hACE2/F-MLN-4760 protein complex was performed for confirmation. Displacement ex</pubmed_abstract><journal>European journal of nuclear medicine and molecular imaging</journal><pubmed_title>Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2.</pubmed_title><pmcid>PMC11599313</pmcid><funding_grant_id>188978</funding_grant_id><funding_grant_id>190414</funding_grant_id><funding_grant_id>310030</funding_grant_id><funding_grant_id>210456</funding_grant_id><pubmed_authors>Mu L</pubmed_authors><pubmed_authors>Schibli R</pubmed_authors><pubmed_authors>Vaccarin C</pubmed_authors><pubmed_authors>Tanriver M</pubmed_authors><pubmed_authors>Deupi X</pubmed_authors><pubmed_authors>He Y</pubmed_authors><pubmed_authors>Benoit R</pubmed_authors><pubmed_authors>Muller C</pubmed_authors><pubmed_authors>Beyer D</pubmed_authors><pubmed_authors>Bode JW</pubmed_authors><pubmed_authors>Wang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2.</name><description>&lt;h4>Purpose&lt;/h4>The angiotensin converting enzyme 2 (ACE2) plays a regulatory role in the cardiovascular system and serves SARS-CoV-2 as an entry receptor. The aim of this study was to synthesize and evaluate radiofluorinated derivatives of the ACE2 inhibitor MLN-4760. [&lt;sup>18&lt;/sup>F]F-MLN-4760 and [&lt;sup>18&lt;/sup>F]F-Aza-MLN-4760 were demonstrated to be suitable for non-invasive imaging of ACE2, potentially enabling a better understanding of its expression dynamics.&lt;h4>Methods&lt;/h4>Computational molecular modeling, based on the structures of human ACE2 (hACE2) and mouse ACE2 (mACE2), revealed that the ACE2-binding modes of F-MLN-4760 and F-Aza-MLN-4760 were similar to that of MLN-4760. Co-crystallization of the hACE2/F-MLN-4760 protein complex was performed for confirmation. Displacement ex</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2026-06-01T13:23:41.323Z</modification><creation>2025-04-04T22:47:37.737Z</creation></dates><accession>S-EPMC11599313</accession><cross_references><pubmed>39066808</pubmed><doi>10.1007/s00259-024-06831-6</doi></cross_references></HashMap>